跳至主要内容
临床试验/IRCT201510244339N12
IRCT201510244339N12已完成2 期

Comparison of the effect of Letrozole and medroxy progesterone on premenopausal patient with endometrial hyperplasia: Randomized Clinical Trial

Vice chancellor of research, Bushehr University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
Female

入选标准

  • women of reproductive age; non-pregnant; the diagnosis of endometrial hyperplasia as ultrasound and pathology.
  • Exclusion criteria: side effects of letrozole; the prohibition of medicine prescription.

排除标准

  • 未提供

研究者

发起方
Vice chancellor of research, Bushehr University of Medical Sciences

相似试验